Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUTOP 2 screen-and-treat strategy for vaginal flora abnormalities in high-risk pregnant women
2023-509421-41-03Phase 3Authorised
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of clotrimazole, azithromycin, doxycycline, metronidazole, lidocaine and 1 more in bacterial vaginosis (BV) and Vaginal dysbiosis (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Planned start Apr 2026; status: authorised.
02
Drugs
clotrimazoleazithromycindoxycyclinemetronidazolelidocaine
03
Conditions
bacterial vaginosis (BV)Vaginal dysbiosis
Beyond the preview
Go deeper on 2023-509421-41-03.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-509421-41-03.